Medpace Holdings, Inc. (FRA:01P)

Market Cap	13.81B +36.7%
Revenue (ttm)	2.01B +13.9%
Net Income	368.98M +18.4%
EPS	12.20 +25.4%
Shares Out	n/a
PE Ratio	37.43
Forward PE	36.35
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	14
Open	504.00
Previous Close	505.60
Day's Range	498.10 - 504.00
52-Week Range	227.70 - 558.20
Beta	n/a
RSI	42.23
Earnings Date	Feb 9, 2026

About Medpace Holdings

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigi...

• Industry: Commercial Physical and Biological Research
• Founded: 1992
• Employees: 6,200
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 01P

Financial Performance

In 2024, Medpace Holdings's revenue was $2.11 billion, an increase of 11.84% compared to the previous year's $1.89 billion. Earnings were $404.34 million, an increase of 43.07%.

Financial numbers in USD